Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy

'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'    

Moderna strikes with a new lawsuit

Moderna is trying to be gatekeeper for the mRNA platform for future drug development, raising monopolistic fears

Charity after profiteering, the Big Pharma way

Pfizer to sell its medicines at no profit in world’s poorest countries, and other big names to make cancer drugs more accessible

Why the US and its allies are stupid to turn COVID-19 vaccination into a geopolitical power play

The COVID-19 pandemic demands that all nations cooperate to vaccinate the entire global population—a goal that can’t be achieved …

Rwanda and Senegal will host Africa’s first COVID-19 vaccine plants: What’s known so far

Only Tunisia, Senegal, Egypt, Ethiopia, and South Africa have varying capabilities to produce and fill or finish vaccines

Norway reports deaths related to COVID-19 vaccination

Situation not alarming, only ‘small exception’ affected by Pfizer mRNA vaccine: Medical director of Norwegian Medicines Agency

Viva Cuba for its vaccine revolution

Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world    

90% efficacy for Pfizer’s COVID-19 mRNA vaccine is striking. But we need to wait for the full data

Important questions remain: It’s unclear how long protection will last and if the vaccine protects against severe disease

COVID-19: Has Big Pharma enabled the rise of omicron

Major drug companies do not want to share the know-how for their vaccines; uneven global vaccine access is now resulting in …

Lateral thoughts: COVID-19 vaccines and a game of chance

Would you be compensated for adverse reactions to the COVID-19 vaccines?  

When generics turn into Big Pharma

Top generics firms, some from India, are charged with price-fixing and sleazy deals; Sun Pharma has paid up to settle claims  

COVID-19 vaccines: Is foreign good for India

The decision to allow foreign vaccines in India may not take plug the current shortage  

Pandemic treaty: Draft urges cooperation, equity, transparency but misses independent monitoring

Draft has evolved from a working document circulated earlier this year in July and builds on the comments made by member states, domain experts …

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

Omicron can partially evade vaccines, booster dose needed : Studies

Vaccinated persons who had contracted COVID-19 in the past have better protection against the disease  

Trade barriers, raw material scarcity can dent hopes for 10 billion COVID-19 vaccines in production

Experts warned of short supply of crucial raw materials; late delivery of bio-reactor giant plastic bags can set back production by weeks, …

Can activism check Big Pharma’s profit motives?

As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma

Update COVID-19 vaccine to target omicron variants: Advisory panel to USFDA

Unclear which combination of updated vaccine will work best; body expected to decide by July

Vaccines work just fine without side effects says a new Lancet study

Only one in four people experience mild, short-lived systemic side-effects after receiving either the Pfizer Inc or the Oxford University-…

Vaccine Watch: 5 dead in Serum Institute fire; UAE okays Sputnik

PM likely to be vaccinated in March or April, doctor in Shivamogga dies two days after receiving jab and Israel denies vaccine efficacy fears

The Pfizer vaccine may not be the best choice for frail people, but it’s too early to make firm conclusions

While the deaths of elderly people in Norway are sad, they shouldn’t be cause for alarm. This actually tells us the vaccine is stimulating …

Pfizer’s COVID-19 vaccine becomes first to get emergency authorisation

UK government gives nod on basis of interim results, vaccine to be made available by next week  

Making COVID-19 vaccines in Africa: Advances and sustainability issues

Demand, market for locally produced vaccines critical for sustainability of 15 COVID-19 vaccines manufacturing facilities

COVID-19 surge: Why has China not attained herd immunity despite high vaccination coverage?

Germany, South Korea, Vietnam are also reporting increase in COVID-19 cases despite extensive vaccination

COVID vaccines: How to make sense of reports on their effectiveness

Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants